Voices
Joaquín Cabrera Rodríguez: PD-L1 Inhibitors Fail to Reduce Brain Metastasis Risk in ES-SCLC
Joaquín Cabrera Rodríguez/LinkedIn

Joaquín Cabrera Rodríguez: PD-L1 Inhibitors Fail to Reduce Brain Metastasis Risk in ES-SCLC

Joaquín Cabrera Rodríguez, Radiation Oncology Specialist at Hospital Universitario de Badajoz, shared a post on X:

“In patients w ES-SCLC, the addition of PD-L1 inhibitors to chemotherapy does not lower the rate of new brain metastasis. PCI was independently associated with a reduced risk of brain metastasis.”

 

Title: Incidence, Risk Factors, and Impact of Immunotherapy on Brain Metastasis in Extensive-Stage Small Cell Lung Cancer Without Baseline Brain Involvement

Authors: Wenli Cao, Xiangjuan Ma, Weiheng Hu, Furong Kou, Yanfei Liu, Jun Nie, Ling Dai, Jie Zhang, Jian Fang, Yang Wang

Read the Full Article.

Joaquín Cabrera Rodríguez: PD-L1 Inhibitors Fail to Reduce Brain Metastasis Risk in ES-SCLC

When ADC Toxicity Is Not the Same for Everyone: A Sex-Based Signal in NSCLC
Joaquín Cabrera Rodríguez: PD-L1 Inhibitors Fail to Reduce Brain Metastasis Risk in ES-SCLC

cancer Furong Kou Jian Fang Jie Zhang Joaquín Cabrera Rodríguez Jun Nie Ling Dai Lung cancer OncoDaily Oncology SCLC Weiheng Hu Wenli Cao Xiangjuan Ma Yanfei Liu Yang Wang